ALLMedicine™ Meningococcal Meningitis Center
Research & Reviews 173 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302495
Human Vaccines & Immunotherapeutics; Xu J, Chen Y et. al.
Jun 11th, 2022 - Invasive meningococcal disease (IMD) caused by Neisseria meningitidis (Nm) continues to be a global public health concern. Understanding the prevalence of Nm serogroups in IMD is critical for developing strategies for meningococcal vaccination. We...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135194
PloS One; Baloche A, Jung C et. al.
May 27th, 2022 - Invasive meningococcal disease (IMD) is still an important cause of mortality in children and survivors can have significant long-term disabling sequelae. There are few prospective studies looking at the long term neuropsychological and developmen...
https://doi.org/10.1016/j.vaccine.2022.05.032
Vaccine Chang CM, Awanye AM et. al.
May 25th, 2022 - Meningococcal meningitis is a rare but serious condition affecting mainly children and young adults. Outer membrane vesicles (OMV) from Neisseria meningitidis have been used successfully as vaccines against the disease, although they only provide ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053794
PloS One; Huang L, Fievez S et. al.
Apr 30th, 2022 - Invasive meningococcal disease (IMD) is life-threatening and associated with substantial morbidity and mortality. The study aimed to examine the clinical characteristics and hospital-based healthcare resource use and related costs following IMD di...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123035
Advances in Therapy; Duval X, Taha MK et. al.
Apr 29th, 2022 - COMBAT is a prospective, multicentre cohort study that enrolled consecutive adults with community-acquired bacterial meningitis (CABM) in 69 participating centres in France between February 2013 and July 2015 and followed them for 1 year. Patients...
Drugs 44 results see all →
Clinicaltrials.gov 13 results
https://clinicaltrials.gov/ct2/show/NCT05093829
Apr 7th, 2022 - Meningococcal meningitis, caused by invasive strains of Neisseria meningitidis, is a major public health concern because of its considerable morbidity and mortality in sub-Saharan Africa. Case fatality during meningococcal meningitis epidemics can...
https://clinicaltrials.gov/ct2/show/NCT04685850
Aug 5th, 2021 - While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year. The objective of this research is to evaluate the sequelae of MM beyond 1 year in patients with a history...
https://clinicaltrials.gov/ct2/show/NCT04211649
Dec 26th, 2019 - Leptospirosis is a globally distributed neglected tropical disease affecting subtropical and tropical areas, such as the Caribbean and the Indian Ocean, with favorable climatic conditions for disease transmission. It shows a strong seasonality, wi...
https://clinicaltrials.gov/ct2/show/NCT03431675
Aug 14th, 2019 - The study is designed as a cluster-randomized trial in the setting of a meningitis epidemic to assess the impact of chemoprophylaxis with single-dose ciprofloxacin on the incidence of meningitis in the study area. The study will be implemented in ...
https://clinicaltrials.gov/ct2/show/NCT03759470
Nov 30th, 2018 - meningitis is a notifiable disease in many countries, the exact incidence rate is unknown. In 2013 meningitis resulted in 303,000 deaths - down from 464,000 deaths in 1990. In 2010 it was estimated that meningitis resulted in 420,000 deaths, exclu...
News 21 results
https://www.onclive.com/view/role-of-leptin-in-the-masp-2-pathway
Apr 26th, 2021 - Samer Khaled, MD: We’ll move on to our next segment and talk about an evolving novel therapy that’s being introduced by Omeros. This is a MASP-2 [mannan-binding lectin serine protease] inhibitor that inhibits the lectin pathway. Just to start with...
https://www.mdedge.com/familymedicine/article/236738/preventive-care/acip-recommendations-covid-19-vaccines-and-more
MDedge Family Medicine; Doug Campos-Outcalt, MD, MPA
Mar 4th, 2021 - The year 2020 was challenging for public health agencies and especially for the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP). In a normal year, the ACIP meets in person 3 times for a.
https://www.staging.medscape.com/viewarticle/940754
Nov 11th, 2020 - Neisseria meningitidis (meningococcus) is a leading cause of bacterial meningitis and septicemia, with about 1.2 million cases of infection and 135,000 deaths globally each year. Because death can rapidly follow infection, cases should be consider...
https://www.medscape.com/viewarticle/940754
Nov 11th, 2020 - Neisseria meningitidis (meningococcus) is a leading cause of bacterial meningitis and septicemia, with about 1.2 million cases of infection and 135,000 deaths globally each year. Because death can rapidly follow infection, cases should be consider...
https://www.mdedge.com/infectiousdisease/article/141684/vaccines/english-infant-quadravalent-group-b-meningococcal-vaccine
Bruce Jancin
Jun 30th, 2017 - MADRID – Cases of invasive meningococcal disease in English 1 year olds dropped fourfold in the first year after the multicomponent group B meningococcal (MenB) vaccine (4CMenB, Bexsero) was added to the national infant immunization list, Shamez L.